Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DSFTP for Stable Angina in Coronary Heart Disease
CTR20160653Phase 2Active
- Sponsor
- Beijing Baotainingtang Biotechnology
- Start
- Aug 2017
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Danshenfentong in coronary arteriosclerosis, angina pectoris, sponsored by Beijing Baotainingtang Biotechnology. Started Aug 2017; status: active.
02
Drugs
Danshenfentong
03
Conditions
coronary arteriosclerosisangina pectoris
Beyond the preview
Go deeper on CTR20160653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160653.